Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urinary Bladder Urothelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01191892
What this trial is testing

Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUreter Cancer+1 more
Cardiff University 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808216
What this trial is testing

Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT

Who this might be right for
Non Muscle Invasive Bladder Cancer
Tianjin First Central Hospital 54
Early research (Phase 1)Study completedNCT02903914
What this trial is testing

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorsColorectal Cancer (CRC)+7 more
Incyte Corporation 260
Large-scale testing (Phase 3)Active Not RecruitingNCT05092958
What this trial is testing

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

Who this might be right for
Advanced Bladder Urothelial CarcinomaAdvanced Renal Pelvis Urothelial CarcinomaAdvanced Ureter Urothelial Carcinoma+15 more
National Cancer Institute (NCI) 654
Not applicableUnknownNCT05139134
What this trial is testing

Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma

Who this might be right for
Urinary Bladder Urothelial Carcinoma
Sohag University 50
Testing effectiveness (Phase 2)Study completedNCT01261728
What this trial is testing

Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Study completedNCT00585689
What this trial is testing

Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer

Who this might be right for
Bladder Cancer
University of Michigan Rogel Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00722553
What this trial is testing

Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

Who this might be right for
Carcinoma, Transitional CellBladder CancerBladder Neoplasm
Acrotech Biopharma Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00343356
What this trial is testing

Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder

Who this might be right for
Bladder Neoplasms
LanZhou University 138
Testing effectiveness (Phase 2)Study completedNCT02736266
What this trial is testing

Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma

Who this might be right for
Urothelial Bladder Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 174
Post-approval studies (Phase 4)Looking for participantsNCT06764095
What this trial is testing

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis and Ureter Urothelial CarcinomaMetastatic Bladder Urothelial Carcinoma+4 more
Mayo Clinic 75
Large-scale testing (Phase 3)Ended earlyNCT04688931
What this trial is testing

UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 282
Testing effectiveness (Phase 2)WithdrawnNCT07414992
What this trial is testing

Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

Who this might be right for
Bladder Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00042887
What this trial is testing

Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 58
Large-scale testing (Phase 3)Looking for participantsNCT07480356
What this trial is testing

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNon-Muscle Invasive Bladder CarcinomaNon-muscle Invasive Bladder Cancer With Carcinoma in Situ
Protara Therapeutics 284
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Testing effectiveness (Phase 2)Study completedNCT05077709
What this trial is testing

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

Who this might be right for
Lung Cancer Non Small CellHead and Neck Squamous Cell CarcinomaUrothelial Carcinoma Bladder
IO Biotech 63
Not applicableUnknownNCT01968928
What this trial is testing

The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma

Who this might be right for
Bladder Urothelial Carcinoma
National Taiwan University Hospital 25
Testing effectiveness (Phase 2)Study completedNCT03339843
What this trial is testing

Multiorgan Metabolic Imaging Response Assessment of Abemaciclib

Who this might be right for
Esophageal AdenocarcinomaEsophagus SCCCholangiocarcinoma+2 more
Jules Bordet Institute 85
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827612
What this trial is testing

Vepugratinib (LY3866288) in Adults With Non-Muscle Invasive Bladder Cancer and Upper Tract Urothelial Cancer

Who this might be right for
Urinary Bladder NeoplasmsUrologic NeoplasmsReceptor, Fibroblast Growth Factor, Type 3
Eli Lilly and Company 161
Next Page